Creating RDF Representations of Patient Data

Slides:



Advertisements
Similar presentations
Hypertension Medications By: Elizabeth Rangel University of the Incarnate Word.
Advertisements

Gold standards Framework and prognostication
Diuretic Strategies in Patients with Acute Decompensated Heart Failure Diuretic Optimization Strategies Evaluation (DOSE) trial.
Hypertension NPN 200 Medical Surgical I. Description of Hypertension Intermittent or sustained elevation in the diastolic or systolic blood pressure:
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Emerging Technologies Semantic Web and Data Integration This meeting will start at 5 min past the hour As a reminder, please place your phone on mute unless.
Clinical Biochemistry FAQ for GP Trainees Dr Mourad Labib Consultant Chemical Pathologist DGOH NHS Foundation Trust July 2009.
DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Physical Wellness Health A / B. Disease Prevention Regular physical activity lowers your risk of many chronic and disabling disease. Why? What is a chronic.
Blood pressure control in primary health care WORKSHOP
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Clinical Observations Interoperability: A Use Case Scenario Rachel Richesson, PhD, MPH * University of South Florida College of Medicine Clinical Observations.
Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.
PREVELANCE OF COMPLICATIONS OF DIABETES MELLITUS IN EGYPT Prof Morsi Arab University of Alexandria.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.
Insulin Optimisation Workshop Theingi Aung & Claire Rowell.
Cardiac Autonomic Neuropathy in Type 2 Diabetes: Predicting Cardiac Risk Margaret M. McCarthy 1 Lawrence Young 2 Silvio Inzucchi 2 Janice Davey 2 Frans.
GO! Diabetes Train the Trainer Program. Practice Performance and Improvement.
Screening System for Hypertension and Diabetes at Primary Care Level
Dr John Cox Diabetes in Primary Care Conference Cork
Nephrology Journal Club The SPRINT Trial Parker Gregg
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Documentation of pharmaceutical care
Redefining Quality Care in T2DM Patients with CV Disease
RDF Representation using POMR of Patient 1
Mastery of Medicine in Diabetes Management Video Roundtable
Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus  S. Nakatani, E.
Visfatin in Type 2 Diabetes Mellitus
Basics of New PHASE Reporting
Hypertension in the Post SPRINT era
Recurrent falls in an older woman with diabetes
Hypertension JNC VIII Guidelines.
Interactive Session- Let’s Talk Orthostatic Hypotension
Defining hypertension
HEART AND CARDIOVASCULAR SYSTEM DISEASES
Chronic Disease Under Control: Diabetes and Hypertension
Vanguard Phase Results for the Blood Pressure Component
Metformin Use in Chronic Kidney Disease
Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline.
Diabetic foot.
Copyright © 2007 American Medical Association. All rights reserved.
Secondary Uses Primary Use EHR and other Auhortities Clinical Trial
Diabetes Mellitus.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Diabetes Health Status Report
COI: Brainstorming Document
P1 rdf:type pomr:PatientRecord rdf:type galen:Patient
Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.
The Hypertension in the Very Elderly Trial (HYVET)
Clinical Observation Interoperability March 18, 2008
Vahab Fatourechi, M. D. , Frank P. Kennedy, M. D. , Robert A. Rizza, M
Clinical Practice Ontology: Version 0.1
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Clinical Element Models
RDF Representation using Detailed Clinical Models of Patient 1
Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz 
CLINICAL PROBLEM SOLVING
Issues With Synthea Generated Patient Data for Use in Clinical Quality Measure – Hypertension Case Study Peter Li, OSEHRA 1/24/2019.
RDF Representation using POMR of Patient 1
(A) Correlation between change in HbA1c and change in weight from baseline to week 24 in the liraglutide group. (A) Correlation between change in HbA1c.
Train-the-Trainer Cases
Use Synthea Generated Patient Data for Clinical Quality Measure – Case Study: CMS165 Controlling High Blood Pressure Peter Li, OSEHRA 2/21/2019.
Chronic Disease Under Control: Managed Care Plan Distribution, 2006
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Train-the-Trainer Cases
Train-the-Trainer Cases
Volume 75, Issue 1, Pages (January 2009)
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Presentation transcript:

Creating RDF Representations of Patient Data

Diabetes Patient Data 54-year-old man with diabetes was referred to the Hypertension Clinic in Jichi Medical School Hospital with symptoms of dizziness and orthostatic intolerance. In 2002, he started insulin therapy (Hemoglobin A1c 9 %), and in 2004, he was started on a once daily dose of valsartan 80 mg for hypertension. He sometimes complained of dizziness and fainting while standing. On 13 February 2005, he fell down while riding a bicycle. As the clinic BP was 84/60 mm Hg on 14 March, and the valsartan was stopped. He was referred to otolaryngology and neurology, but no significant abnormalities were detected.

URI subject? or has_symptom? age? “54 years” “Collection of Symptoms” _1 _2 “Dizziness” “Orthostatic Intolerance” maps_to maps_to Snomed URI2 Snomed URI1

Design Choices What are the nodes of this graph? What are the types of the nodes of this graphs (RDF(S)/OWL Classes)? What are the labels of the edges of this graph? How do we decide the classes and instances? How do we deal with Industry Standards such as RIM/CDA/SDTM/DCM + Snomed/NCI Thesaurus etc.? Can node types and edge labels be derived from these standards? Can we have specialized edge (“maps_to”) to link nodes in this graph with Snomed/NCI Thesaurus concepts? How do we choose these to ensure interoperability across multiple standards? How do we represent temporal data and information? How do we capture abstractions such as a clinical event, a patient encounter?

Name Space Issues Proposal: Create Namespaces for each of the standards hl7rim: HL7/RIM dcm: Detailed Clinical Models cda: Clinical Documentation Architecture sdtm: Study Data Tabulation Model snomed: Snomed ncit: NCI Thesaurus

How do we scope this effort? Systolic Blood Pressure Known head injury Suspected head injury Pregnancy Type 2 diabetes FPG HbA1c Women of childbearing potential Type 1 diabetes Ketacidosis History of <Condition/Diagnosis> Severe Diabetic Neuropathy Autonomic Neuropathy Gastroporesis Lower Limb Ulceration Lower Limb Amputation Intentional Weight Loss Period of time for Weight Loss Serum creatinine eGFR Chronic Kidney Disease Stage 3

Proposed Tasks/Groups HL7/RIM: Helen, Vipul, Dan DCM: Tom Oniki, Stan Huff Realist Approach: Kerstin, Bo, Alan SDTM: Rachel, Jennifer POMR: Vipul

Examples of Eligibility Criteria Example Patient Data Various Standards HL7, CDISC, etc. RDF/OWL Graphs